AXL and non-small cell lung carcinoma: Our recent study showed that NF-kB signaling pathway was involved in the AXL-associated invasiveness and drug resistance, and dual inhibition of NF-kB and AXL phosphorylation by sulfasalazine may provide an opportunity to effectively attenuate the invasiveness and drug resistance of NSCLC cells8.